Sort
82,697 grants matching “vaccine development”
Software for sequencing human antibody proteins from polyclonal immune responses
$779,009Anand Patel · Abterra Biosciences, Inc. · R44 · FY2021 · GM
Rapid Point of Care Detection of HPV-Associated Malignancies
$778,995Karen Sue Anderson · Arizona State University-Tempe Campus · UH3 · FY2019 · CA
Pathogenic Determinants of SIV Envelope Glycoproteins
$778,978University Of Pennsylvania · R01 · FY2004 · AI
Physical Resources Core
$778,959Justin Joseph Pollara · Duke University · P01 · FY2024 · AI
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$778,923Petros C Karakousis · Johns Hopkins University · R01 · FY2024 · AI
Effective CMV-based SIV vaccine regimens for newborn infants via IL-10 modulation
$778,922Dennis J Hartigan-O'Connor · University Of California At Davis · R01 · FY2020 · AI
Impact of the Intestinal Microbiome on HIV/SIV Vaccines
$778,914Megan T Baldridge · Washington University · R01 · FY2019 · OD
Multivalent nanocluster universal influenza vaccine given by microneedle patch
$778,900Baozhong Wang · Georgia State University · R01 · FY2019 · AI
The role of immune cells in Alzheimer's disease
$778,844Arya Biragyn · National Institute On Aging · ZIA · FY2017 · AG
Early Life B-cell and plasma cell development in the human Spleen: a new paradigm for lifelong immunity
$778,829Eliver Ghosn · Emory University · R01 · FY2025 · AI
Papillomavirus Virion Proteins and Vaccines
$778,823Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Infant immune mechanisms of HIV reservoir size and decay
$778,821Grace C John-Stewart · University Of Washington · R01 · FY2017 · HD
Identification of novel immunogenic proteins from Bordetella pertussis
$778,804Purnima Dubey · Ohio State University · R01 · FY2021 · AI
Biocontainment Research Support Services Core
$778,799Karen Marie Dobos · Colorado State University · UC7 · FY2023 · AI
The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques
$778,756Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
HIV-1 Env protein structure and function assessed by parallel smFRET and cryoET
$778,747Walther H Mothes · Yale University · R37 · FY2025 · AI
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$778,698Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
Development of an Adhesin-Toxoid Chimera Vaccine for Enterotoxigenic E. coli
$778,669Stephen J Savarino · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2006 · AI
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$778,661Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Protective biomarkers for the development of vaccines against malaria
$778,631Philip Louis Felgner · Immport Therapeutics, Inc. · R44 · FY2014 · AI
Identification of the Initial Targets of Transmission
$778,558Thomas Hope · Northwestern University At Chicago · R37 · FY2021 · AI
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
$778,536Joseph A Duncan · Univ Of North Carolina Chapel Hill · U01 · FY2024 · AI
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
$778,478David A Williams · Boston Children'S Hospital · U01 · FY2021 · AI
Modulation of innate and adaptive immunity of filoviruses in macaques
$778,455Thomas William Geisbert · Georgia State University · U19 · FY2016 · AI
Mechanisms of protection against shigellosis in children
$778,440Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2022 · AI